Overview

Variant ID 25294
Entrez Gene ID 29072
Gene SETD2 (GeneCards)
Location hg19 3:47112785-47112785
hg38 3:47071295-47071295
Disease Asymptomatic
Method Single cell Sequencing Cell cloning
Mutation(HGVS format) NC_000003.11:g.47112785 C>A (Genome Assembly: GRCh37)

Other information

Exon or Intron NA
Position in protein NA
Amino acid changes in protein NA > NA
Position in cDNA NA
Changes in cDNA NA > NA
mRNA accession NA
mRNA length NA
Reference length 198022430

Annotations and predictions

MAF in gnomAD genome (version 2.0.1) 0
EIGEN score -0.0329
CADD Raw score (version 1.3) 0.209789 (Deleterious)
FATHMM raw prediction score 0.11573 (Tolerated)
Deleterious probability by DeFine 0.5497 (Deleterious)
Entrez Gene ID 29072 (NCBI Gene)
Official Gene Symbol SETD2 (GeneCards)
Number of variants in SETD2 in this database 33 (view all the variants)
Full name SET domain containing 2
Band 3p21.31
Other IDs Vega: OTTHUMG00000133514
OMIM: 612778
HGNC: HGNC:18420
Ensembl: ENSG00000181555
Other names LLS, HYPB, SET2, HIF-1, HIP-1, KMT3A, HBP231, HSPC069, p231HBP
Summary Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]

Individual #1

Individual ID 29217587.03 (view all the variants in this individual)
Pubmed ID 29217587
Whose mosaic mutation Normal  
Phenotype 1  
Disease Asymptomatic
OMIM ID